What adjunctive medication should be added to sertraline 200 mg daily for anxiety?

Add Cognitive Behavioral Therapy (CBT) to Sertraline 200 mg for Anxiety

The strongest evidence supports adding structured Cognitive Behavioral Therapy (CBT) rather than another medication to sertraline 200 mg for anxiety disorders. 1

Primary Recommendation: CBT Augmentation

If the patient has not already received CBT, this should be the first-line augmentation strategy. The evidence shows:

• Combination treatment (CBT + SSRI) is superior to medication alone for social anxiety, generalized anxiety, separation anxiety, and panic disorder 1
• CBT should be structured with approximately 14 individual sessions over 4 months (60-90 minutes each), following either the Clark & Wells or Heimberg model 2
• This approach improves primary anxiety symptoms, global function, response rates, and remission rates with moderate strength of evidence 1

Key consideration: Sertraline 200 mg is already at the maximum FDA-approved dose 3. Before adding medications, ensure the patient has received an adequate trial duration (12 weeks minimum for full effect) 1.

If CBT is Not Feasible or Has Failed

For Specific Anxiety Disorder Types:

For OCD with anxiety:

• Consider adding aripiprazole (10-15 mg/day) - has the strongest evidence from two placebo-controlled trials 4
• Alternative: risperidone (particularly if comorbid tic disorder or depressive symptoms) 4
• Quetiapine and olanzapine have controversial efficacy 4

For Generalized Anxiety Disorder:

• Consider adding buspirone (10-15 mg/day) - shown efficacious in elderly patients with GAD, well-tolerated 5
• Evidence for antipsychotic augmentation (olanzapine, quetiapine, ziprasidone, risperidone) in SSRI-resistant GAD is negative or insufficient 4

For PTSD with anxiety:

• Prazosin - reduces PTSD symptoms, sleep disturbances, nightmares, and psychological distress 4
• Risperidone showed benefit in some trials 4
• Olanzapine may help with sleep disturbances 4

For Social Anxiety Disorder:

• Limited evidence; pindolol augmentation showed no benefit 4
• Switch to another SSRI (escitalopram) or SNRI (venlafaxine) rather than augment 2

Important Caveats and Pitfalls:

1. Verify adequate trial duration: SSRIs show maximal improvement by week 12 or later 1. Many patients are switched prematurely.

2. Assess adherence: Confirm the patient is actually taking 200 mg daily before adding agents 1

3. Rule out behavioral activation: At 200 mg, consider whether anxiety is a dose-related adverse effect rather than treatment resistance 1

4. Monitor for serotonin syndrome if adding any serotonergic agent. Sertraline interacts with drugs metabolized by CYP2D6 1

5. Consider switching rather than augmenting: Guidelines suggest switching to escitalopram, fluvoxamine, paroxetine, or venlafaxine as an alternative strategy 2

What NOT to Add:

• Avoid benzodiazepines as first-line augmentation (only second-line per Canadian guidelines) 2
• Avoid beta-blockers (atenolol, propranolol) - negative evidence 2
• Avoid quetiapine for GAD - failed trials 4

Practical Algorithm:

1. First: Ensure 12-week adequate trial at 200 mg with confirmed adherence
2. Second: Add structured CBT (14 sessions over 4 months)
3. Third (if CBT unavailable/failed): Choose based on specific disorder:
   • OCD → aripiprazole 10-15 mg
   • GAD → buspirone 10-15 mg
   • PTSD → prazosin
   • Social anxiety → consider switching SSRI rather than augmenting

The evidence base for pharmacological augmentation of treatment-resistant anxiety disorders remains limited 4, making CBT augmentation the most evidence-based approach when sertraline monotherapy at maximum dose is insufficient.